Global (United States, European Union and China) Human Prothrombin Complex Market Research Report 2019-2025 (Includes Business Impact of COVID-19)

  • TBI534323
  • September 18, 2019
  • Global
  • 139 pages
  • TSCIR
                                          

Abstract, Snapshot, Market Analysis & Market Definition: World Human Prothrombin Complex Market

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.The global average price of Human Prothrombin Complex is in the increasing trend, from 124 USD/Unit in 2013 to 137 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.The classification of Human Prothrombin Complex includes 500 IU/Vial, 600 IU/Vial, 1000 IU/Vial and others, and the proportion of 500 IU/Vial in 2017 is about 51%.Human Prothrombin Complex is widely used in Hemophilia B, Vitamin K Deficiency and other diseases. The most proportion of Human Prothrombin Complex is Hemophilia B, and the proportion of sales is 48%.North America is the largest consumption place, with a consumption market share nearly 46% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 33%.Market competition is not intense. Shire, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. In 2019, the market size of Human Prothrombin Complex is 1115.2 million US$ and it will reach 2427 million US$ in 2025, growing at a CAGR of 11.8% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Prothrombin Complex. This report studies the global market size of Human Prothrombin Complex, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India, and Southeast Asia). This study presents the Human Prothrombin Complex sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019

Market Segmentation, Outlook & Viewpoint: World Human Prothrombin Complex Market

Segmentation by Product Type: Breakdown of data from the year 2014 to 2019 and forecast until 2025: 500 IU/Vial 600 IU/Vial 1000 IU/Vial Others Segmentation by Application: Breakdown of data from the year 2014 to 2019 and forecast until 2025: Hemophilia B Vitamin K Deficiency Others

Top Companies & Key Players: World Human Prothrombin Complex Market

Takeda CSL Grifols Octapharma Hualan Biological Meheco Xinxing Pharma

Key Insights Covered: World Human Prothrombin Complex Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue, and growth rate) of Human Prothrombin Complex industry. 2. Global major manufacturers' operating situation (sales, revenue, growth rate, and gross margin) of Human Prothrombin Complex industry. 3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue, and growth rate) of Human Prothrombin Complex industry. 4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Human Prothrombin Complex industry. 5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Human Prothrombin Complex industry.

Research Methodology: Global Human Prothrombin Complex Market

  • Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  • Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  • Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.

 1 Report Overview    1.1 Study Scope    1.2 Major Manufacturers Covered in This Report    1.3 Market Segment by Type
1.3.1 Global Human Prothrombin Complex Market Size Growth Rate by Type (2019-2025)
1.3.2 500 IU/Vial
1.3.3 600 IU/Vial
1.3.4 1000 IU/Vial
1.3.5 Others    1.4   
1.4.1 Global Human Prothrombin Complex Market Share by Application (2019-2025)
1.4.2 Hemophilia B
1.4.2 Vitamin K Deficiency
1.4.2 Others    1.5 Study Objectives    1.6 Years Considered2 Global Growth Trends    2.1 Global
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form